Fecal microbiota transplant (FMT) as a treatment for C. difficile infections has skyrocketed over the past decade. While it has saved tens of thousands of lives, FMT remains controversial and the Food and Drug Administration (FDA) has been slow to formalize its regulatory status. This has left doctors, scientists, drug …
The Food and Drug Administration (FDA) issued a Safety Alert today Regarding Use of Fecal Microbiota for Transplantation and Additional Safety Protections Pertaining to COVID-19. According to the alert, “FDA is informing health care providers and patients of the potential risk of transmission of SARS-CoV-2 virus by the use of fecal …
On March 12, the Food and Drug Administration (FDA) issued a safety alert that eight patients were infected following fecal microbiota transplants (FMT) using material from a company which was later confirmed to be OpenBiome, an independent stool bank. Two of the patients subsequently died. FDA did not name OpenBiome …
In recognition of C. diff Awareness Month, this past November Peggy Lillis Foundation (PLF) launched our new public education campaign, “See C. diff.” The campaign was based from Cdiff.org and included a range of educational media. We are delighted to report that the campaign did incredibly well reaching hundreds of …
Our Rhode Island-based Advocate Meg Mimnaugh published an op-ed in the Providence Journal to promote PLF’s “See C. diff” public education campaign. My Turn: Americans should know about deadly infection Losing a loved one is always painful. It’s particularly excruciating when their death was preventable. Before my mom died from …
